GM (GM), Ford (F), and Chrysler better pick up the pace of their sales in China. It is about the only place where anyone is buying cars. China car sales ... Read Full Story »
It has probably occurred to the management at Dow Chemical (DOW) that it can not win a suit brought by Rohm and Haas (ROH) to force Dow to complete its buyout. The early ... Read Full Story »
It is hard to understand what is happening with the Chinese economy. The central government says that GDP grew almost 7% in the fourth quarter. At the same time, it ... Read Full Story »
GM (GM) is preparing to go through another round of layoffs. It has hopes, which are probably futile, that it can push out enough people, in addition to getting creditor ... Read Full Story »
How many banks will fail in the US over the next year as the recession deepens? Answering that is like trying to guess whether a poker player will draw an ... Read Full Story »
Most of the focus of the recession has been on the US and China. It makes sense to try to examine economic activity in the world’s largest consuming economy and ... Read Full Story »
According to Reuters, the White House is finishing a bank rescue package , that involves investment by private equity. Reuters reports that a poll of analysts cut Q2 earnings forecasts. ... Read Full Story »
Markets in Asia were narrowly mixed. The Nikkei Fell .3% to 7,946. The Hang Seng rose .4% to 13,825. The Shanghai Composite was up 1.8% to 2,265. In Europe, at ... Read Full Story »
If you can believe it, there is an initial public offering on deck this week. Bristol-Myers Squibb Co. (NYSE: BMY) is set to partially spin off Mead Johnson Nutrition (NYSE: ... Read Full Story »
Starbucks (SBUX) announced today that customers will be able to buy a coffee and breakfast item for $3.95. Can Starbucks afford to do that with its relatively high costs of ... Read Full Story »
General Electric Co. (NYSE: GE) may have moved more today on a percentage basis than in any single day in many investors' lifetimes. (more...) ... Read Full Story »
ViroPharma (VPHM) Drug trial fails. Huge drop to $4.89 from 52-week high of $15.16. Insight Enterprises (NSIT) Plans to restate earnings. Falls to $2.69 from 52-week high of $19.25. Popular ... Read Full Story »
AOL's plan to capture a large part of the online ad market is to organize a number of brands, some of which don't have the AOL name, into a new ... Read Full Story »
USG Corporation (NYSE: USG) had an important vote today that essentially allows Warren Buffett and Berkshire Hathaway Inc. (NYSE: BRK-A) to get much more control of the company. (more...) ... Read Full Story »
iSupply, the tech market researcher, noted that memory shipments were much softer than expected in Q4. While that part of the report is a no-brainer, iSupply is looking for ... Read Full Story »